消息

HealthEquity, Inc. (NASDAQ: HQY) announced its fourth‑quarter and fiscal 2026 earnings date of March 17 2026, with a conference call scheduled for 4:30 p.m. Eastern. The company reaffirmed its guidance for fiscal 2026 and fiscal 2027, citing strong sales in Q4 and a record number of new HSA accounts.

全文

Going forward, HCKT anticipates sequential revenue growth in Global S&BT and Oracle segments as new AI delivery platforms mature. A go‑to‑market pilot with ServiceNow is scheduled for January 2026, and an international channel partnership will deploy AI XPLR across 26 industries to generate leads and provide ROI models. Current consensus estimates...

全文

Capital‑market activity included a share repurchase of 2.1 million shares at an average price of $20.30 per share and a dividend declaration of $0.12 per share for Q1 2026. A stock tender offer and additional repurchase authorization brought the total shares acquired to 4.1 million for approximately $55 million. The company plans to incur AI transi...

全文

Segment performance was mixed: Global SMET revenue fell 11 % year‑over‑year, whereas SAP Solutions revenue rose 32 % driven by strong software sales and S/4HANA cloud migrations. Management highlighted a strategic shift from labor‑based delivery to AI‑enabled services, leveraging proprietary Gen‑AI platforms and Hackett Solution Language Models to...

全文

Hackett Group (HCKT) reported Q4 2025 earnings of $0.40 per share, surpassing the Zacks Consensus Estimate of $0.39 per share (+3.44%). Revenue for the quarter ended December 2025 was $74.82 million, exceeding the consensus estimate by 6.66%. The company’s adjusted gross margin stood at 46.6 %, while adjusted EBITDA reached $15.9 million, or 21.3 %...

全文

Strategic risks highlighted include the potential Warner Brothers acquisition, rising utility costs, and uncertainty around Netflix’s theatrical sincerity. Cinemark remains skeptical of Netflix’s theatrical sincerity and is targeting accretive M&A assets and underpenetrated markets for new builds. The company’s balanced approach—extinguishing debt,...

全文

Concession revenues reached all‑time highs, and per‑capita concession revenue improved, driven by strategic pricing, higher incidence rates, and a shift in product mix. Analysts anticipate a 4.5 % decline in Q4 revenue to $777.75 million and an 18.2 % year‑over‑year drop in EPS to $0.27. Average U.S. ticket prices are projected to rise to $11.08 an...

全文

Management outlined a $250 million capital‑expenditure plan for 2026, allocating $50–$60 million internationally and the remainder to U.S. new‑build and premium‑format projects. The focus is on reactivating new‑build pipelines, expanding XD and ScreenX, and optimizing the circuit through AI‑driven pricing and operational efficiencies. Cinemark expe...

全文

Cinemark operates 496 theaters with 5,637 screens in 42 U.S. states and 13 Latin‑American countries. The company’s domestic market share grew by more than 100 basis points relative to pre‑pandemic levels, while its U.S. Movie Club membership increased by over 50 % since 2019. Alternative programming now accounts for more than 10 % of box‑office rev...

全文

Cinemark Holdings (CNK) reported a post‑pandemic high for 2025 with worldwide revenue of $3.1 billion and adjusted EBITDA of $578 million, yielding an 18.6% margin. The company extinguished over $700 million of COVID‑related debt and returned $315 million to shareholders through dividends and share buybacks. Revenue for the quarter ended December 3...

全文